Mestranol

Mestranol

Gene therapy
Clinical data
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name (8S,9S,13S,14S,17S)-17-ethynyl-3-methoxy- 13-methyl-7,8,9,11,12,14,15,16-octahydro-6H- cyclopenta[a]phenanthren-17-ol
CAS Number	72-33-3
PubChem Template:Abbreviation	6291
Chemical and physical data
Formula	C21H26O2
Molar mass	310.43 g/mol

WikiDoc Resources for Mestranol
Articles
Most recent articles on Mestranol Most cited articles on Mestranol Review articles on Mestranol Articles on Mestranol in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mestranol Images of Mestranol Photos of Mestranol Podcasts & MP3s on Mestranol Videos on Mestranol
Evidence Based Medicine
Cochrane Collaboration on Mestranol Bandolier on Mestranol TRIP on Mestranol
Clinical Trials
Ongoing Trials on Mestranol at Clinical Trials.gov Trial results on Mestranol Clinical Trials on Mestranol at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mestranol NICE Guidance on Mestranol NHS PRODIGY Guidance FDA on Mestranol CDC on Mestranol
Books
Books on Mestranol
News
Mestranol in the news Be alerted to news on Mestranol News trends on Mestranol
Commentary
Blogs on Mestranol
Definitions
Definitions of Mestranol
Patient Resources / Community
Patient resources on Mestranol Discussion groups on Mestranol Patient Handouts on Mestranol Directions to Hospitals Treating Mestranol Risk calculators and risk factors for Mestranol
Healthcare Provider Resources
Symptoms of Mestranol Causes & Risk Factors for Mestranol Diagnostic studies for Mestranol Treatment of Mestranol
Continuing Medical Education (CME)
CME Programs on Mestranol
International
Mestranol en Espanol Mestranol en Francais
Business
Mestranol in the Marketplace Patents on Mestranol
Experimental / Informatics
List of terms related to Mestranol

Mestranol is the 3-methyl ether of ethinylestradiol. It was the estrogen used in many of the first oral contraceptives.

It is a biologically inactive prodrug of ethinylestradiol to which it is demethylated in the liver with a conversion efficiency of 70% (50 µg of mestranol is pharmacokinetically bioequivalent to 35 µg of ethinylestradiol).